
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
Sulfonylureas or metformin are reasonable initial-medication choices to slow the progression of diabetes.






